Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tumor progression is a multistep process in which proproliferation mutations must be accompanied by suppression of senescence. In melanoma, proproliferative signals are provided by activating mutations in NRAS and BRAF, whereas senescence is bypassed by inactivation of the p16(Ink4a) gene. Melanomas also frequently exhibit constitutive activation of the Wnt/beta-catenin pathway that is presumed to induce proliferation, as it does in carcinomas. We show here that, contrary to expectations, stabilized beta-catenin reduces the number of melanoblasts in vivo and immortalizes primary skin melanocytes by silencing the p16(Ink4a) promoter. Significantly, in a novel mouse model for melanoma, stabilized beta-catenin bypasses the requirement for p16(Ink4a) mutations and, together with an activated N-Ras oncogene, leads to melanoma with high penetrance and short latency. The results reveal that synergy between the Wnt and mitogen-activated protein (MAP) kinase pathways may represent an important mechanism underpinning the genesis of melanoma, a highly aggressive and increasingly common disease.

Original publication




Journal article


Genes Dev

Publication Date





2923 - 2935


Animals, Cell Line, Transformed, Cell Transformation, Neoplastic, Cells, Cultured, Chromatin Immunoprecipitation, Crosses, Genetic, Cyclin-Dependent Kinase Inhibitor p16, Electrophoretic Mobility Shift Assay, Gene Silencing, Genes, ras, Humans, Luciferases, Melanocytes, Melanoma, Mice, Mice, Transgenic, Transfection, beta Catenin, beta-Galactosidase